BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21167860)

  • 1. The potential economic value of a hookworm vaccine.
    Lee BY; Bacon KM; Bailey R; Wiringa AE; Smith KJ
    Vaccine; 2011 Feb; 29(6):1201-10. PubMed ID: 21167860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting.
    Bartsch SM; Hotez PJ; Hertenstein DL; Diemert DJ; Zapf KM; Bottazzi ME; Bethony JM; Brown ST; Lee BY
    Vaccine; 2016 Apr; 34(19):2197-206. PubMed ID: 27002501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm.
    Bottazzi ME; Brown AS
    Expert Rev Vaccines; 2008 Dec; 7(10):1481-92. PubMed ID: 19053205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis.
    Hotez PJ; Bethony JM; Oliveira SC; Brindley PJ; Loukas A
    Expert Rev Vaccines; 2008 Aug; 7(6):745-52. PubMed ID: 18665774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries.
    Diemert DJ; Lobato L; Styczynski A; Zumer M; Soares A; Gazzinelli MF
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005327. PubMed ID: 28114401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil.
    Gazzinelli MF; Lobato L; Matoso L; Avila R; de Cassia Marques R; Shah Brown A; Correa-Oliveira R; Bethony JM; Diemert DJ
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e749. PubMed ID: 20651933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human hookworm vaccine: recent updates and prospects for success.
    Bottazzi ME
    J Helminthol; 2015 Sep; 89(5):540-4. PubMed ID: 25850789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
    Diemert DJ; Freire J; Valente V; Fraga CG; Talles F; Grahek S; Campbell D; Jariwala A; Periago MV; Enk M; Gazzinelli MF; Bottazzi ME; Hamilton R; Brelsford J; Yakovleva A; Li G; Peng J; Correa-Oliveira R; Hotez P; Bethony J
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005574. PubMed ID: 28464026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines for hookworm infection.
    Hotez PJ; Ghosh K; Hawdon J; Narasimhan S; Jones B; Bethony J
    Pediatr Infect Dis J; 1997 Oct; 16(10):935-40. PubMed ID: 9380467
    [No Abstract]   [Full Text] [Related]  

  • 10. New technologies for the control of human hookworm infection.
    Hotez PJ; Bethony J; Bottazzi ME; Brooker S; Diemert D; Loukas A
    Trends Parasitol; 2006 Jul; 22(7):327-31. PubMed ID: 16709466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative.
    Hotez PJ; Zhan B; Bethony JM; Loukas A; Williamson A; Goud GN; Hawdon JM; Dobardzic A; Dobardzic R; Ghosh K; Bottazzi ME; Mendez S; Zook B; Wang Y; Liu S; Essiet-Gibson I; Chung-Debose S; Xiao S; Knox D; Meagher M; Inan M; Correa-Oliveira R; Vilk P; Shepherd HR; Brandt W; Russell PK
    Int J Parasitol; 2003 Sep; 33(11):1245-58. PubMed ID: 13678639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A step forward in the journey towards hookworm vaccines.
    Keiser J; Bouchery T
    Lancet Infect Dis; 2024 Jul; 24(7):673-674. PubMed ID: 38513685
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty-five-year research progress in hookworm excretory/secretory products.
    Abuzeid AMI; Zhou X; Huang Y; Li G
    Parasit Vectors; 2020 Mar; 13(1):136. PubMed ID: 32171305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Human Hookworm Vaccine.
    Hotez PJ; Diemert D; Bacon KM; Beaumier C; Bethony JM; Bottazzi ME; Brooker S; Couto AR; Freire Mda S; Homma A; Lee BY; Loukas A; Loblack M; Morel CM; Oliveira RC; Russell PK
    Vaccine; 2013 Apr; 31 Suppl 2(Suppl 2):B227-32. PubMed ID: 23598487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental approaches to the development of a recombinant hookworm vaccine.
    Hotez PJ; Ghosh K; Hawdon JM; Narasimhan S; Jones B; Shuhua X; Sen L; Bin Z; Haechou X; Hainan R; Heng W; Koski RA
    Immunol Rev; 1999 Oct; 171():163-71. PubMed ID: 10582170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Global Economic and Health Burden of Human Hookworm Infection.
    Bartsch SM; Hotez PJ; Asti L; Zapf KM; Bottazzi ME; Diemert DJ; Lee BY
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004922. PubMed ID: 27607360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hookworm vaccines: past, present, and future.
    Loukas A; Bethony J; Brooker S; Hotez P
    Lancet Infect Dis; 2006 Nov; 6(11):733-41. PubMed ID: 17067922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled human infection models to evaluate schistosomiasis and hookworm vaccines: where are we now?
    Koopman JPR; Driciru E; Roestenberg M
    Expert Rev Vaccines; 2021 Nov; 20(11):1369-1371. PubMed ID: 34225549
    [No Abstract]   [Full Text] [Related]  

  • 19. Hookworm vaccines.
    Diemert DJ; Bethony JM; Hotez PJ
    Clin Infect Dis; 2008 Jan; 46(2):282-8. PubMed ID: 18171264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An economic evaluation of expanding hookworm control strategies to target the whole community.
    Turner HC; Truscott JE; Bettis AA; Shuford KV; Dunn JC; Hollingsworth TD; Brooker SJ; Anderson RM
    Parasit Vectors; 2015 Nov; 8():570. PubMed ID: 26542226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.